Multiple sclerosis in US minority populations: Clinical practice insights

What is it about?

This is a letter to the Ed explaining that African-Americans (AA) get the short shrift when it comes to multiple sclerosis research and as patients, AA recruitment is conspicuous by its absence in clinical trials.

Featured Image

Why is it important?

African American disease is aggressive, disability status is worse compared to age and gender matched cohorts and drug-effectiveness is poor. Hence, MORE research is needed in this cohort, not less.